Speakers

Please see below for a list of our confirmed speakers so far, in alphabetical order:

• Sheera Adar, The Adar Lab, Israel

• Alberto Bardelli, University of Torino, Italy

• Yinon Ben-Neriah, The Hebrew University of Jerusalem, Israel

• Giulia Biffi, Cancer Research UK, Cambridge Institute, United Kingdom

• Gideon Bollag, Opna Bio, USA

• Giovanni Ciriello, University of Lausanne (UNIL), Switzerland

• Alessio Ciulli, University of Dundee, Ciulli Lab, United Kingdom

• Johann de Bono, The Institute of Cancer Research, Drug Development Unit, United Kingdom

• Zoi Diamantopoulou, University of Glasgow, United Kingdom

• Mustafa Diken, BioNTech AG, Germany

• Neta Erez, Tel Aviv University, Israel

• Keith Flaherty, Harvard University, Mass General Institute, USA

• Evangelos Giampazolias, University of Manchester, United Kingdom

• Vera Gorbunova, University of Rochester, United States

• Petra Hamerlik, The University of Manchester, United Kingdom

• Kairbaan Hodivala-Dilke, Barts Cancer Institute, United Kingdom

• Guillaume Jacquemet, University of Turku, Finland

• Camilla Jandus, Jandus Lab, Switzerland

• Phil Jones, Cambridge Stem Cell Institute, United Kingdom

• Johanna A. Joyce, Ludwig Institute for Cancer Research, Switzerland

• Leeat Keren, Weizmann Institute of Science, Israel

• Guido Kroemer, The Kroemer Lab, France

• Stefan Laufer, University of Tuebingen, Germany

• Anthony George Letai, Harvard University, United States

• Erez Levanon, The Goodman Faculty of Life Sciences, Israel

• Leanne Li, The Francis CRICK Institute, United Kingdom

• Marcos Malumbres, CNIO, Spain

• Silvia Marsoni, Silvia Marsoni Lab, Italy

• Seamus J. Martin, Trinity College Dublin, The Martin Lab, Ireland

• Yifat Merbl, The Merbl Lab, Israel

• Peter Nagy, National Institute of Oncology, Hungary

• Renato Ostuni, IFOM-IEO, Italy

• Marina Pasca di Magliano, University of Michigan, Medical School, United States

• Attila Pattocs, National Institute of Oncology, Hungary

• Daniel Peeper, Netherlands Cancer Institute, Netherlands

• Michael Platten, University of Heildelberg, Medical Faculty Mannheim, Germany

• Yuliya Pylayeva-Gupta, UNC School of Medicine, United States

• Timothy R. Rebbeck, Harvard T.H. Chan School of Public Health, United States

• Yardena Samuels, Weizmann Institute of Science, Israel

• Owen Sansom, School of Cancer Sciences, United Kingdom

• Victoria Sanz-Moreno, King's College London, United Kingdom

• Adrian Saurin, University of Dundee, School of Medicine, United Kingdom

• Christoph Scheiermann, University of Geneva, Switzerland

• Joan Seoane, Vall d’Hebron Institute of Oncology (VHIO), Spain

• Darrin Stuart, Novartis, Switzerland

• Zoltan Szallasi, Boston Children's Hospital, United States

• Tuomas Tammela, The Tuomas Tammela Lab, United States

• Li Tang, EPFL, Switzerland

• Chris Tape, University College London, United Kingdom

• Andreas Trumpp, Heidelberg Institute for Stem Cell Technology, Germany

• Jacco van Rheenen, Netherlands Cancer Institute, Netherlands

• Ashani T. Weeraratna, John Hopkins Bloomberg School of Public Health, United States

• Elisabete Weiderpass, International Agency for Research on Cancer (IARC), France

• Sabine Werner, ETH Zurich, Switzerland

• Richard White, University of Oxford, Ludwig Institute for Cancer Research, United Kingdom